Slideshow
New Discovery Grant Awarded by MS Society of Canada
Heterogeneity in the MS prodrome & impact on disease progression (PrOMS-HD). Clinical Research Project Grant Type: Discovery Grant (operating) by Multiple Sclerosis Society of Canada Total Funding – $99,983 (Canadian dollar) Funding Competitive?: Yes Funding Reference Number: (EGID): 903124 Multiple Funding Bodies
Top 3% of researchers cited globally (recognition).
Posted May/2022: Ioannidis JPA, Baas J, Klavans R, Boyack KW (2019) A standardized citation metrics author database annotated for scientific field.
ACTRIMS Forum 2023
The ACTRIMS Forum 2023, San Diego, California, Conference Date: 2023/2 Risk of Multiple Sclerosis in People with HIV: An International Cohort study. Authors: E. Kingwell, A. Manouchehrinia, F. Zhu, K. McKay, J. Li, M. Ye, P. Sereda, J. Trigg, K. Kooij, M. Gisslén, A. Ekström, J. Hillert, R. Hogg, H. Tremlett. Presentation Type: Oral Presentation […]
New Blog: Tremlett’s MS Research Explained
Written by Sharon Roman, a patient-partner and writer for the British Medical Journal group, Tremlett’s MS Research Explained is dedicated to explaining our work in plain language.
Emergency Department Use Among Persons with MS
Jonas Graf and team presented a poster on “Emergency department visits by persons with MS: a population-based study” at the 2021 ECTRIMS conference. Health administration data from persons with MS in British Columbia and emergency department (ED) visits from the National Ambulatory Care Reporting System were used to investigate ED use among people with MS. […]
Featured Researcher in Fall 2021 endMS Newsletter
Huah Shin Ng was featured in the endMS Spotlight on the Future newsletter! This summer, she graduated from the 2020-2021 Scholar Program for Researchers IN Training (SPRINT). Her SPRINT project reviewed the role of macrophages and microglia in progressive MS. Read more about Huah Shin and her work in the newsletter.
Interview on Real Talk MS: The MS Prodrome with Dr. Helen Tremlett
Dr. Helen Tremlett was interviewed on MS Talk’s 202nd episode about her presentation on the MS prodrome. Dr. Tremlett co-chaired the virtual workshop, hosted by the MS Society of Canada in partnership with the National MS Society, where she presented. While prodromal Parkinson’s Disease has been recognized and studied since the 80s, in contrast, many […]
Natural Improvements in MS are Possible
Multiple sclerosis (MS) patients sometimes experience “natural” improvements in disability.
Afsaneh Shirani’s New Beta Interferon Study published in JAMA
Beta Interferon not associated with reducing Long-Term disease progression in patients with relapsing remitting MS